T cell proliferation assay

Ended Purchase Order Awarded Last action

Contract number
75F40121P00423
Awardee
Awarding agency
Obligated
$79,658

Award facts

Opportunity
Contract value 100% obligated
$79,658.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Total Small Business
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · The purpose of this modification is to DE-obligate excess funds and close out the contract. -$1
Original award $79,659

About this award

The Food and Drug Administration awarded a purchase order to Proimmune, Inc. for $79,658.00 to provide T cell proliferation assay services, with an ultimate completion date of July 28, 2026. The award carries a Total Small Business set-aside. Work is performed in Silver Spring, Maryland. This modification de-obligates excess funds and closes out the contract. The solicitation was posted July 6, 2021, with a due date of July 21, 2021, and the order was awarded August 9, 2021.

Quick answers

Who was awarded contract 75F40121P00423?

75F40121P00423 was awarded to Proimmune, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 9, 2021.

How much is contract 75F40121P00423 worth?

The government has obligated $79,658 on 75F40121P00423.

Was contract 75F40121P00423 competed?

The extent of competition for 75F40121P00423 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award